Winston D Byblow1,2, Cathy M Stinear1,3, P Alan Barber1,3, Matthew A Petoe1,3,4, Suzanne J Ackerley1,3. 1. Center for Brain Research, University of Auckland, Auckland, New Zealand. 2. Department of Sport & Exercise Science, University of Auckland, Auckland, New Zealand. 3. Department of Medicine, University of Auckland, Auckland, New Zealand. 4. Bionics Institute of Australia, Melbourne, Australia.
Abstract
OBJECTIVE: For most patients, resolution of upper limb impairment during the first 6 months poststroke is 70% of the maximum possible. We sought to identify candidate mechanisms of this proportional recovery. We hypothesized that proportional resolution of upper limb impairment depends on ipsilesional corticomotor pathway function, is mirrored by proportional recovery of excitability in this pathway, and is unaffected by upper limb therapy dose. METHODS: Upper limb impairment was measured in 93 patients at 2, 6, 12, and 26 weeks after first-ever ischemic stroke. Motor evoked potentials (MEPs) and motor threshold were recorded from extensor carpi radialis using transcranial magnetic stimulation, and fractional anisotropy (FA) in the posterior limbs of the internal capsules was determined with diffusion-weighted magnetic resonance imaging. RESULTS: Initial impairment score, presence of MEPs and FA asymmetry were the only predictors of impairment resolution, indicating a key role for corticomotor tract function. By 12 weeks, upper limb impairment resolved by 70% in patients with MEPs regardless of their initial impairment, and ipsilesional rest motor threshold also resolved by 70%. Resolution of impairment was insensitive to upper limb therapy dose. INTERPRETATION: These findings indicate that upper limb impairment resolves by 70% of the maximum possible, regardless of initial impairment, but only for patients with intact corticomotor function. Impairment resolution seems to reflect spontaneous neurobiological processes that involve the ipsilesional corticomotor pathway. A better understanding of these mechanisms could lead to interventions that increase resolution of impairment above 70%.
OBJECTIVE: For most patients, resolution of upper limb impairment during the first 6 months poststroke is 70% of the maximum possible. We sought to identify candidate mechanisms of this proportional recovery. We hypothesized that proportional resolution of upper limb impairment depends on ipsilesional corticomotor pathway function, is mirrored by proportional recovery of excitability in this pathway, and is unaffected by upper limb therapy dose. METHODS:Upper limb impairment was measured in 93 patients at 2, 6, 12, and 26 weeks after first-ever ischemic stroke. Motor evoked potentials (MEPs) and motor threshold were recorded from extensor carpi radialis using transcranial magnetic stimulation, and fractional anisotropy (FA) in the posterior limbs of the internal capsules was determined with diffusion-weighted magnetic resonance imaging. RESULTS: Initial impairment score, presence of MEPs and FA asymmetry were the only predictors of impairment resolution, indicating a key role for corticomotor tract function. By 12 weeks, upper limb impairment resolved by 70% in patients with MEPs regardless of their initial impairment, and ipsilesional rest motor threshold also resolved by 70%. Resolution of impairment was insensitive to upper limb therapy dose. INTERPRETATION: These findings indicate that upper limb impairment resolves by 70% of the maximum possible, regardless of initial impairment, but only for patients with intact corticomotor function. Impairment resolution seems to reflect spontaneous neurobiological processes that involve the ipsilesional corticomotor pathway. A better understanding of these mechanisms could lead to interventions that increase resolution of impairment above 70%.
Authors: Matthew S Jeffers; Boris Touvykine; Allyson Ripley; Gillian Lahey; Anthony Carter; Numa Dancause; Dale Corbett Journal: J Neurosci Date: 2020-06-30 Impact factor: 6.167
Authors: Heidi M Schambra; Jing Xu; Meret Branscheidt; Martin Lindquist; Jasim Uddin; Levke Steiner; Benjamin Hertler; Nathan Kim; Jessica Berard; Michelle D Harran; Juan C Cortes; Tomoko Kitago; Andreas Luft; John W Krakauer; Pablo A Celnik Journal: Neurorehabil Neural Repair Date: 2019-06-06 Impact factor: 3.919
Authors: Josep Puig; Gerard Blasco; Gottfried Schlaug; Cathy M Stinear; Pepus Daunis-I-Estadella; Carles Biarnes; Jaume Figueras; Joaquín Serena; Maria Hernández-Pérez; Angel Alberich-Bayarri; Mar Castellanos; David S Liebeskind; Andrew M Demchuk; Bijoy K Menon; Götz Thomalla; Kambiz Nael; Max Wintermark; Salvador Pedraza Journal: Neuroradiology Date: 2017-03-14 Impact factor: 2.804
Authors: Rebecca Lewthwaite; Carolee J Winstein; Christianne J Lane; Sarah Blanton; Burl R Wagenheim; Monica A Nelsen; Alexander W Dromerick; Steven L Wolf Journal: Neurorehabil Neural Repair Date: 2018-02 Impact factor: 3.919